Superworth

Shattuck Labs EPS STTK

Diluted earnings per share by quarter and over the last twelve months, from 2019.

Last 12 months, to Jun 30, 2026
−$0.51
Latest quarter, Q2 FY26
−$0.12
Fiscal year 2025
−$0.77

Shattuck Labs' earnings per share was −$0.51 over the twelve months to Jun 30, 2026.

In its latest quarter, Q2 FY26, it was −$0.12.

Earnings per share over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearEPSChange
FY2025−$0.77n/a
FY2024−$1.49n/a
FY2023−$2.05n/a
FY2022−$2.41n/a
FY2021−$1.06n/a
FY2020−$3.52n/a
FY2019n/an/a

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedEPSOn a year earlierLast 12 months
Q2 FY26−$0.12n/a−$0.51
Q1 FY26−$0.13n/a−$0.63
Q4 FY25−$0.12n/a−$0.77
Q3 FY25−$0.14n/a−$1.02
Q2 FY25−$0.24n/a−$1.21
Q1 FY25−$0.27n/a−$1.39
Q4 FY24−$0.37n/a−$1.49
Q3 FY24−$0.33n/a−$1.53
Q2 FY24−$0.42n/a−$1.85
Q1 FY24−$0.37n/a−$1.93
Q4 FY23−$0.41n/a−$2.05
Q3 FY23−$0.65n/a−$2.24

Against its peers

Companies in Drug Manufacturers - General nearest Shattuck Labs' size, closest first, today.

CompanyEPS, 12 monthsGrowth
STTKShattuck Labs−$0.51
PBYIPuma Biotechnology$0.52−47% a year
IRWDIronwood Pharmaceuticals$0.77
ZVRAZevra Therapeutics$0.93
CRMDCorMedix$2.13+184% a year
ARVNArvinas$0.16
COLLCollegium Pharmaceutical$1.24+19% a year
ABUSArbutus Biopharma$0.78
AMPHAmphastar Pharmaceuticals$1.70−36% a year
OMEROmeros$1.52
NATRNatures Sunshine Products$1.01+36% a year
Peer median$0.97

What the EPS figure tells you

Net income divided by diluted shares. The denominator of PE.

One-off charges and gains swing it. The TTM view smooths a single odd quarter.

More on Shattuck Labs

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.